Professor Yaakov (Koby) Nahmias is the Director of the Alexander Grass Center for Bioengineering at The Hebrew University of Jerusalem. He is the head of the university’s MicroLiver Technologies Laboratory, and the creator of BioDesign Israel, a multidisciplinary, team-based approach, which connects clinicians from the Hadassah Medical Center and outstanding bioengineering and business graduate students from The Hebrew University, and tutors them in bringing medical innovations to the market.
Since joining HU in 2009, Professor Nahmias has been awarded a major European Research Council (ERC) Starting Grant and the Rappaport Prize for Biomedical Sciences. Earlier in his career, Professor Nahmias was on the faculty of Harvard Medical School, during which time he received a prestigious National Institute of Health Career Award.
A recognized expert in liver biology and metabolism, Professor Nahmias has authored more than 50 peer-reviewed papers, and a book titled, Microdevices in Biology and Medicine. His work is published in leading scientific journals, among them, the Proceedings of the National Academy of Sciences (PNAS), Cell Metabolism, Nature Medicine and Nature Biotechnology. Professor Nahmias is a member of the ERC Biotechnology Panel (LS9).
Professor Nahmias earned his B.Sc. at the Technion-Israel Institute of Technology, and his Ph.D. at the University of Minnesota. He completed his postdoctoral training at Massachusetts General Hospital.